Literature DB >> 7074524

Ocular side effects of cancer chemotherapy.

M Vizel, M W Oster.   

Abstract

The ocular side effects of cancer chemotherapeutic drugs are relatively uncommon. Patients with cancer may develop ocular problems due to metastases to the eye or central nervous system, side effects and radiotherapy or chemotherapy, or totally independent eye disorders. We present a review of the reported ocular toxicities of chemotherapeutic agents to assist the oncologist caring for such patients.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7074524     DOI： 10.1002/1097-0142(19820515)49:10<1999::aid-cncr2820491009>3.0.co;2-b

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


  11 in total

1.  Transient blindness and seizure associated with cisplatin therapy.

Authors:  M T Cattaneo; V Filipazzi; E Piazza; E Damiani; G Mancarella
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

2.  Visual failure and optic atrophy associated with chlorambucil therapy.

Authors:  P H Yiannakis; A J Larner
Journal:  BMJ       Date:  1993-01-09

3.  Effects on the visual system might contribute to some of the cognitive deficits of cancer chemotherapy-induced 'chemo-fog'.

Authors:  R B Raffa; R J Tallarida
Journal:  J Clin Pharm Ther       Date:  2010-06       Impact factor: 2.512

4.  Effects of selected repeated intravitreal chemotherapeutic agents.

Authors:  J Vernot; G A Peyman; R Gailitis; R Fiscella; M Woodhouse; D Weinberg
Journal:  Int Ophthalmol       Date:  1985-11       Impact factor: 2.031

5.  Chemotherapy of eyelid and peritorbital tumors.

Authors:  M N Luxenberg; T H Guthrie
Journal:  Trans Am Ophthalmol Soc       Date:  1985

Review 6.  Punctal and canalicular stenosis associated with systemic fluorouracil therapy. Report of five cases and review of the literature.

Authors:  H M Brink; L V Beex
Journal:  Doc Ophthalmol       Date:  1995       Impact factor: 2.379

Review 7.  Clinically important ocular reactions to systemic drug therapy.

Authors:  I G Rennie
Journal:  Drug Saf       Date:  1993-09       Impact factor: 5.606

8.  Ocular surface and tear film abnormalities in women under adjuvant chemotherapy for breast cancer with the 5-Fluorouracil, Epirubicin and Cyclophosphamide (FEC) regimen.

Authors:  A Karamitsos; V Kokkas; A Goulas; P Paraskevopoulos; K Gougoulias; V Karampatakis; K Boboridis
Journal:  Hippokratia       Date:  2013-04       Impact factor: 0.471

9.  Uveoretinal Adverse Effects Presented during Systemic Anticancer Chemotherapy: a 10-Year Single Center Experience.

Authors:  Ah Ran Cho; Young Hee Yoon; June Gone Kim; Yoon Jeon Kim; Joo Yong Lee
Journal:  J Korean Med Sci       Date:  2018-02-12       Impact factor: 2.153

Review 10.  Ocular toxicity of systemic anticancer chemotherapy.

Authors:  Afekhide Ernest Omoti; Caroline Edijana Omoti
Journal:  Pharm Pract (Granada)       Date:  2006-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.